Triple drug therapy for the treatment and prevention of acute or chronic pain
OwnerDavid M. Ockertinventor
Life of this patent
Estimating the term…
Abstract
A triple drug therapy, pharmaceutical kit, composition, and method of treatment regimen utilized as a combination of effective amounts of an anxiolytic agent, centrally acting alpha antiadrenergic agent, and central nervous system stimulant for the reduction or prevention of dizziness, drowsiness, depression, delirium, lethargy, mania, orthostatic hypotension, restlessness, weakness in the extremities, and difficulty in being mobile negative side effects caused by therapeutic agents utilized in the treatment of acute and chronic pain syndromes.
Claims67
A pharmaceutical kit for the treatment of acute and chronic pain syndrome comprising the combination of:
- at least one anxiolytic agent;
- at least one centrally acting alpha antiadrenergic agent;
- and
- at least one central nervous system stimulant agent.
A pharmaceutical composition for the treatment of acute and chronic pain syndrome comprising a combination of at least one anxiolytic agent;
- at least one centrally acting alpha antiadrenergic agent;
- and at least one central nervous system stimulant agent.
A method for treating and preventing acute and chronic pain syndrome, administering separately, but contemporaneously, a combination of at least one anxiolytic agent, at least one centrally acting alpha antiadrenergic agent, and at least one central nervous system stimulant agent.
Dependencies are inferred from the claim text.